Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions

NCT06456086 is registered in ClinicalTrials.gov with First Affiliated Hospital of Kunming Medical University as lead sponsor.

NCT NCT06456086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06456086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions
Lead sponsor
First Affiliated Hospital of Kunming Medical University
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2020
Completion date
October 31, 2024
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reactions